Background: Low urine pH is related to obesity and insulin resistance, which are components of metabolic syndrome (MS). Th e aim of this study was to identify the relation between a low urine pH and MS after controlled for other covariates including demographic and lifestyle factors in adult Korean population. Materials and Methods: We analyzed data from the 2010 Korea National Health and Nutrition Examination Survey, a cross-sectional and nationally representative survey and 1960 men and 2702 women were included in this study. Study subjects were divided into the group with urine pH <5.5 and the group with urine pH ≥5.5 refer to literature. We then evaluated the association between low urine pH and MS. Results: After adjusting for age, sex, smoking status, drinking status, regular exercise, and blood urea nitrogen level, the odds ratio (OR) for the presence of MS in the group with urine pH <5.5 was 1.350 (95% confi dence interval [95% CI]: 1.158-1.573) using the American Heart Association/ National Heart, Lung, and Blood Institute criteria or 1.304 (95% CI: 1.082-1.572) using the International Diabetes Federation criteria. Among MS components, elevated fasting glucose (OR: 1.231, 95% CI: 1.058-1.433, P = 0.007) and elevated triglyceride (TG) (OR: 1.389, 95% CI: 1.189-1.623, P < 0.001) showed a signifi cantly high OR. Conclusion: Th e fi ndings confi rmed that low urine pH is associated with MS in the Korean population. Among MS components, elevated fasting glucose and elevated TG showed a signifi cantly high OR.
have reported a relationship of unduly acidic urine (pH <5.5) with obesity, diabetes mellitus, and insulin resistance, which are components of MS. [10] [11] [12] Another study reported an inverse correlation between urine pH and the number of MS components, [13] and a recent cohort study proposed a low level of urine pH as both a causative factor and a predictive factor for the development of MS. [14] However, in these studies, infl uential factors aff ecting metabolic disease, such as smoking, alcohol consumption, and exercise, were not considered.
Therefore, the aim of this study was to identify the relation between a low urine pH and MS a er controlled for other covariates including demographic and lifestyle factors in adult Korean population using a nationally representative sample.
INTRODUCTION
Metabolic syndrome (MS) is a combined expression of the characteristics of metabolic disorders including hypertension, insulin resistance, obesity, dyslipidemia, [1] which increase the risk of developing type 2 diabetes mellitus, renal diseases, and cardiovascular disease. [2, 3] Adult MS is prevalent, with an incidence rate of 20-30% in most countries. [4] Among various biologic markers, the homeostatic model assessment insulin resistance index (HOMA-IR) and gamma-glutamyl transferase (GGT) levels are the most strongly related to MS; [5] levels of highsensitivity C-reactive protein, [6] cystatin C, [7] uric acid, [8] and alanine aminotransferase (ALT) [9] have also been associated with MS. In addition, some studies
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MATERIALS AND METHODS

Study subjects
The subjects and data were obtained from the fi h Korea National Health and Nutrition Examination Surveys (KNHANES V-1), a cross-sectional and nationally representative survey with a stratified, multistage, probability sampling design conducted by the Korea Centers for Disease Control and Prevention in 2010. The KNHANES consisted of the Health Interview Survey, Health Examination, and Nutrition Survey. Detailed information regarding the design of the survey has been reported previously. [15] In brief, the fi h (2010-2012) KNHANES were conducted annually using a rolling sampling design. The target population of the survey was noninstitutionalized civilians older than 1-year in South Korea. Sampling units were defi ned based on geographic area, gender, and age group using the household registries from the National Census Registry. A total of 10,938 people from 3840 households in 192 national districts were randomly sampled and 8473 (77.5% of the target population) participated in the survey, respectively.
Among adults aged >19 years who fasted for >8-h before undergoing a urine test, those with a known history of renal failure, those with a serum creatinine level ≥1.2 mg/ dL, and those who were pregnant were excluded from the survey. A total of 4662 adults (1960 men and 2702 women) were included in this study.
Measurements
Sociodemographic characteristics, medical and surgical histories, medication history, anthropometric data, blood and urine tests and nutritional data were examined. Smoking status was subcategorized into "never smoker," "former smoker," and "current smoker," and drinking status was subcategorized into "drinking alcohol" and "not." Alcohol drinking was indicated as "yes" for participants who consumed at least one glass of alcohol every month over the last year. Regular exercise was defi ned as moderate occupational or physical activities (slow-paced swimming; playing doubles tennis, volleyball, badminton, or table tennis; and carrying light objects for >30 min 5 times/week) or vigorous occupational or physical activities (jogging, climbing a mountain, fast-paced cycling or swimming, playing football or basketball, jumping rope, playing squash, playing singles tennis, and carrying heavy objects for >20 min 3 times/week). The exercise group was defined as subjects who had been performing regular exercise. Regular walking was defi ned as walking for >30 min 5 times/week.
Height and weight were measured down to the fi rst decimal place, and body mass index (BMI) was calculated as body weight (kg) divided by the square of height (m). Using a tape measure waist circumference (WC) was measured from the half-way point between the lower line of the last rib and the upper line of the iliac crest when a subject exhaled and was measured down to the fi rst decimal place. Blood pressure (BP) was measured 3 times with an interval of 30 s a er resting for 5 min in a si ing position. The fi nal BP was defi ned as the average BP of the second and third BP measurements.
Blood samples were collected from the antecubital vein following an 8-h fasting period. The samples were kept in a refrigerator once they were processed and delivered to the central laboratory in Seoul. The analysis of all samples was performed within 24-h. Measurement of fasting glucose, total cholesterol, triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), ALT, and GGT levels was performed using an enzyme technique (Hitachi Automatic Analyzer 7600, Hitachi, Japan). Blood urea nitrogen (BUN) was measured with a kinetic ultraviolet method and creatinine was measured with a colorimetric method. Insulin level was measured with a radioimmunoassay using a 1470 WIZARD gamma-counter (PerkinElmer, Finland). Creatinine clearance was calculated using Cockcro -Gault equation. [16] HOMA-IR was calculated as (fasting plasma insulin [μU/mL] × fasting plasma glucose [FPG] [mg/dL])/ (22.5 × 18.182). [17] The quantitative insulin-sensitivity check index (QUICKI) was calculated as 1/(log fasting insulin [μU/mL] + log fasting blood sugar [mg/dL]). [18] The early morning midstream urine was collected for urine chemistry following an 8-h fasting period and analyzed using an automated urine dipstick analyzer (Urisys 2400, Roche, Germany). Urine specimen was immediately refrigerated a er collection and analyzed in 24-h. The analysis of nutritional values, including total calories, protein, fat, fi ber, and sodium was performed by trained dietitians on the basis of the individuals' 24-h dietary recall method.
Defi nition of metabolic syndrome
Metabolic syndrome was defi ned according to the 2005 American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) [19] and International Diabetes Federation (IDF) criteria. [20] The WC thresholds for the defi nition of abdominal obesity in Koreans were determined as 90 cm for men and 85 cm for women. [21] Statistical analysis Taking into account the complex sampling design of the KNHANES, to minimize selection errors, the results were estimated with consideration for the primary sampling unit and stratifi cation variables and sampling weights.
Descriptive data were expressed as the mean value (standard error) or number (%). The independent t-test was employed for analysis of continuous variables and the Chi-square test for analysis of categorical variables. The diff erences in general characteristics, sociodemographic parameters, dietary parameters, anthropometric parameters, general characteristics of the group with urine pH <5.5 and the group with urine pH ≥5.5, biochemical results, and risk factors for MS were analyzed according to variables using the independent t-test and Chi-square test. Multiple logistic regression was used for the analysis of relative risk factors of those with urine pH <5.5 compared with those with urine pH ≥5.5. Age and sex were primarily adjusted, and BUN, smoking status, drinking status, and regular exercise were secondarily adjusted for the analysis. Statistical signifi cance was defi ned as a P < 0.05. Data were analyzed using SPSS version 18.0 for Windows (SPSS Inc., Chicago, IL, USA).
RESULTS
Baseline characteristics
The general characteristics of the subjects are shown in Table 1 . In total, 1960 men and 2702 women were included in the analysis. The average age was 44.9 years and the mean BMI was 23.6 kg/m 2 . The mean FPG was 96.3 mg/dL and the mean urine pH was 5.7. Fasting insulin, total cholesterol, and LDL-C levels were not statistically diff erent between men and women (P > 0.05).
Characteristics of study variables by urine pH
The group with urine pH <5.5 and the group with urine pH ≥5.5 were compared for multiple parameters including sociodemographic, dietary, anthropometric, kidney function, and metabolic parameters [ Table 2 ]. No statistically signifi cant diff erence in age and sex was observed between those with urine pH <5.5 and those with urine pH ≥5.5. No diff erences in alcohol consumption, regular walking, as well as calories, protein, fat, fi ber, and sodium consumption were observed between the groups. Conversely, signifi cant diff erences in smoking and regular Data are expressed as the mean ± SE; The differences between men and women were statistically significant (P Data are expressed as the mean ± SE or the number (%); P value by two-sample t-test or Chi-square test; BP = Blood pressure; HOMA-IR = Homeostatic model assessment insulin resistance; QUICKI = Quantitative insulin-sensitivity check index; ALT = Alanine aminotransferase; GGT = Gamma-glutamyl transferase; LDL-C = Low-density lipoprotein cholesterol; HDL-C = High-density lipoprotein cholesterol; SE = Standard error; BMI = Body mass index; WC = Waist circumference; SBP = Systolic blood pressure; DBP = Diastolic blood pressure; BUN = Blood urea nitrogen; FPG = Fasting plasma glucose; TG = Triglyceride exercise were observed between the groups (P = 0.001 and P = 0.032, respectively).
The BMI of those with urine pH <5.5 was higher than that of those with urine pH ≥5.5 (P = 0.038); however, no diff erence in abdominal circumference and BP was observed. BUN levels diff ered signifi cantly between the groups; however, no signifi cant diff erence in creatinine levels and creatinine clearance were observed between the groups. The fasting glucose level, insulin level, and HOMA-IR of subjects with urine pH <5.5 were higher than subjects with urine pH ≥5.5 (P < 0.001, P = 0.005, and P < 0.001, respectively), but the QUICKI was signifi cantly lower (P < 0.001). The group with urine pH <5.5 showed a high GGT level (P = 0.014). No signifi cant diff erence in LDL-C level was observed between the groups; however, the HDL-C level was lower and the TG level was higher in the group with urine pH <5.5 (P < 0.001 and P < 0.001, respectively).
Prevalence of metabolic syndrome and its components by urine pH
Applying both AHA/NHLBI and IDF criteria, MS was more prevalent in subjects with urine pH <5.5 than subjects with urine pH ≥5.5 (P = 0.001 and P = 0.005, respectively) [ Table 3 ]. In the group with urine pH <5.5, 24.3% had abdominal obesity, which was more than the percentage of the group with urine pH ≥5.5 (21.3%; P = 0.036), and 26.3% of those with urine pH <5.5 had an abnormal fasting glucose level (fasting glucose ≥100 mg/ dL or medication), which was more than the percentage of the group with urine pH ≥5.5 (22.8%; P = 0.016). The percentage with high TG levels was also signifi cantly higher in the group with urine pH <5.5, with 33.9% having an abnormal value (P < 0.001). No diff erences in metabolic components for elevated BP and low HDL-C were observed between the groups.
Odds ratio of metabolic syndrome and its components by urine pH
The crude odds ratio (ORs), age-and sex-adjusted ORs (model 1), and multivariable-adjusted ORs (model 2) for MS and the components of MS by urine pH status are shown in Table 4 . A er adjusting for age, sex, smoking status, drinking status, regular exercise, and BUN level, the OR for the presence of MS in the group with urine pH <5.5 was 1.350 (95% confi dence interval [95% CI], 1.158-1.573, P < 0.001) using AHA/NHLBI criteria or 1.304 (95% CI, 1.082-1.572, P = 0.005) using the IDF criteria. Among MS components, elevated fasting glucose (OR = 1.231, 95% CI: 1.058-1.433, P = 0.007), reduced HDL-C (OR = 1.195, 95% CI: 1.013-1.409, P = 0.035), and elevated TG level (OR = 1.389, 95% CI: 1.189-1.623, P < 0.001) showed signifi cantly high ORs. Model 1 = Adjusted for age and sex (age adjustment unit was 1-year; sex adjustment range was men and women); Model 2 = Adjusted for age, sex, BUN, smoking status, drinking status and regular exercise (BUN adjustment unit was 1, smoking status adjustment range was smoking/quit smoking/never smoked, drinking status adjustment range was drinking alcohol/not, regular exercise adjustment range was performing regular exercise/not performing regular exercise). OR = Odds ratio; 95% CI = 95% confi dence interval; AHA/NHLBI = American heart association/national heart, Lung and Blood Institute; IDF = International diabetes federation; MS = Metabolic syndrome; BP = Blood pressure; FPG = Fasting plasma glucose; HDL-C = High-density lipoprotein cholesterol; TG = Triglyceride; BUN = Blood urea nitrogen
DISCUSSION
In this cross-sectional study, we suggested that urine pH <5.5 is associated with MS. Among MS components, elevated fasting glucose and elevated TG showed a signifi cantly high OR.
It is known that urine pH decreases with aging, [22] with a high protein diet and low fi ber diet, [23, 24] and when renal function is deteriorated. [25] In addition, another study showed that increased fa y acid provision associated with low urine pH. [26] However, the results of this study show that age, protein intake, lipid intake, and fi ber intake did not aff ect urine pH, although smoking status and the regular exercise did aff ect urine pH. Considering the diff erence of serum BUN levels between the groups, we believed that our failure to present the infl uence of a high protein diet resulted from our failure to perform an accurate assessment of eating habits because we used a 24-h recollection survey for diet assessment.
The acid-base balance of urine is regulated according to production and excretion of NH 3 , a urinary buff er. In patients with insulin resistance, production of NH 3 from proximal tubules is reduced and ammonia excretion is also reduced accordingly, resulting in low urine pH. [27] In addition, in patients with insulin resistance, sodium absorption is increased because of hyperinsulinemia, which also lowers urine pH. [24] Insulin resistance in subjects with MS is believed to be associated with a lower urine pH; this is supported by the strong relation between hyperglycemia and urine pH presented in this study.
The current fi ndings are consistent with those from previous studies. [13, 14, 28] In a study of 148 people who did not have urolithiasis or renal failure, using 24-h urine collection, a negative correlation was observed between blood glucose, systolic BP, triglyceridemia, and urine pH, and a positive correlation was observed between serum HDL-C level and urine pH. [13] In another study conducted in 1503 male subjects, a low urine pH showed an association with greater WC; insulin resistance; and levels of fasting glucose, glycosylated hemoglobin, serum TG, and HDL-C. [28] In the above-mentioned study, BP was not associated with a low urine pH value, and this result was reconfi rmed in this study. In this study, WC did not show a statistically signifi cant OR value. This was believed to be due to various unmeasured confounding factors aff ecting urine pH that were modifi ed before the results were deducted. A recent retrospective cohort study conducted in Japan [14] reported that a low urine pH is a causative factor for the development of MS. However, important confounding variables related to the prevalence of MS, such as smoking habit, alcohol intake, and dietary habit, were not investigated in this study.
To the best of our knowledge, this is the only study examining the association between urine pH and MS a er controlled for other covariates including demographic and lifestyle factors. The urine pH test, using a urine dipstick, is regarded as a relatively simple and noninvasive method, and risk factors for MS should be assessed if urine pH <5.5.
This study has a few limitations that need to be addressed. The fi rst is that the nutritional assessment was performed using a 24-h dietary recall method. In this study, daily protein intake was not associated with urine pH. A er review of the results of another study examining changes in urine pH according to diet, [23] we believe that the relation between diet and urine pH should be examined using a more accurate nutritional assessment. The second limitation is the absence of information regarding urolithiasis. The third limitation is that spot urine samples were used instead of 24-h urine samples. However, it is known that spot urine pH was correlated with 24-h urine pH [29] and fasting early morning samples were used in this study. We identifi ed urinary pH using urine dipstick analyzers, and it is another limitation because this test method is limited to determine the exact level of urine pH. However, there were prior studies that measured urine pH using urine dipstick test. [14, 28] The fi nal limitation is that this study was conducted as a crosssectional study; therefore, the order of the incidence between a low urine pH and MS cannot be clearly identifi ed. Despite these limitations, our fi ndings are signifi cant because this is a large-scale study including representative Korean adults.
CONCLUSION
This large scale cross-sectional study confirmed the association between low urine pH and MS in the Korean population.
